– The campaign marks the successful commercial-scale PPQ completion of Asia’s first 3 X 5,000L single-use bioreactors– Proprietary process innovation reduces protein cost by nearly 70% while boosting yield 20%– As the company’s largest operational […]
Tag: WuXi Biologics
WuXi Biologics Receives CDMO Leadership Awards for Eighth Consecutive Year
SHANGHAI, March 23, 2025 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has received 2025 CDMO Leadership Awards in the “Biologics – Global” […]
WuXi Biologics Named to CDP Water Security “A List” for Second Consecutive Year
Launching the Water Excellence Stewardship (WES) program to advance UN Sustainable Development Goal 6 (SDG6) Contributing to the 2025 World Water Day campaign to ensure the availability of water and sanitation for all SHANGHAI, March […]
WuXi Biologics Included in S&P Global Sustainability Yearbook 2025
Ranking in top 1% of S&P Global CSA Score Inclusion in Global Yearbook for third consecutive year Leader in Green CRDMO to drive innovation for a healthier future SHANGHAI, March 10, 2025 /PRNewswire/ — WuXi Biologics […]
WuXi Biologics Launches EffiX™ Microbial Expression Platform to Boost Recombinant Protein and Plasmid DNA Production
– EffiX™ is designed to meet the industry’s demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a comprehensive solution for the development and manufacturing of non-monoclonal antibody (non-mAb) recombinant […]
